Ryan F. Robinson's most recent trade in Tourmaline Bio Inc was a trade of 76,400 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tourmaline Bio Inc | Ryan F. Robinson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 76,400 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Ryan F. Robinson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 58,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Ryan F. Robinson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 25,845 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Ryan F. Robinson | CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Oct 2025 | 16,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Ryan F. Robinson | CFO | 28 Oct 2025 | 14,366 | 0 | - | - | Common Stock | ||
| Tourmaline Bio Inc | Ryan F. Robinson | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.92 per share. | 22 Oct 2025 | 14,366 | 14,366 | - | 13.9 | 199,975 | Common Stock |
| Tourmaline Bio Inc | Ryan F. Robinson | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Oct 2025 | 14,366 | 25,845 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Ryan F. Robinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 58,000 | 58,000 | - | - | Employee Stock Option (Right to Buy) | |
| Tourmaline Bio Inc | Ryan F. Robinson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 76,400 | 76,400 | - | - | Employee Stock Option (Right to Buy) |